Peter Thiel-backed Lindus Health has raised $55 million as it sets about "fixing the broken clinical trial industry." ...

Shares of Vigil Neuroscience , Inc. (NASDAQ:VIGL) climbed 14% after the company reported favorable results from its Phase 1 ...

The design for a medical study in 1743 that was never carried out may have inspired James Lind’s groundbreaking clinical ...

Rigel has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, fostamatinib, to ...

SOUTH SAN FRANCISCO - ALX Oncology Holdings Inc. (NASDAQ:ALXO), a clinical-stage biotechnology company with a market capitalization of approximately $95 million, reported positive outcomes from its ...

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...

Royal Wolverhampton NHS Trust (RWT), the home of the NIHR West Midlands Regional Research Delivery Network, was to host the ...

We ran a Q&A With Michael Young, co-founder of Lindus Health on the challenges of 2024 and the company’s goals for 2025.

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

Up to 200 subjects will receive four curated strains never before given in combination as a synbiotic treatment, as part of a development plan to improve infant health outcomes -SAN DIEGO, Jan. 23, ...

Sanford Health is teaming up with Medtronic to test a procedure aimed at reducing medication dependency for high blood ...

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage ...